摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1,1',6,6',7,7'-hexahydroxy-3,3'-dimethyl-2,2'-binaphthyl-5,5'-diyl)bis(benzo[d]thiazol-2-ylmethanone) | 1146624-44-3

中文名称
——
中文别名
——
英文名称
(1,1',6,6',7,7'-hexahydroxy-3,3'-dimethyl-2,2'-binaphthyl-5,5'-diyl)bis(benzo[d]thiazol-2-ylmethanone)
英文别名
US9115061, Xvii;[6-[5-(1,3-benzothiazole-2-carbonyl)-1,6,7-trihydroxy-3-methylnaphthalen-2-yl]-2,3,5-trihydroxy-7-methylnaphthalen-1-yl]-(1,3-benzothiazol-2-yl)methanone
(1,1',6,6',7,7'-hexahydroxy-3,3'-dimethyl-2,2'-binaphthyl-5,5'-diyl)bis(benzo[d]thiazol-2-ylmethanone)化学式
CAS
1146624-44-3
化学式
C38H24N2O8S2
mdl
——
分子量
700.749
InChiKey
YCUCYHOUGDRKQJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    10
  • 重原子数:
    50
  • 可旋转键数:
    5
  • 环数:
    8.0
  • sp3杂化的碳原子比例:
    0.05
  • 拓扑面积:
    238
  • 氢给体数:
    6
  • 氢受体数:
    12

文献信息

  • NAPHTHALENE-BASED INHIBITORS OF ANTI-APOPTOTIC PROTEINS
    申请人:Pellecchia Maurizio
    公开号:US20090105319A1
    公开(公告)日:2009-04-23
    Methods of using apogossypol and its derivatives for treating inflammation is disclosed. Also, there is described a group of compounds having structure A, or a pharmaceutically acceptable salt, hydrate, N-oxide, or solvate thereof are provided: wherein each R is independently selected from the group consisting of H, C(O)X, C(O)NHX, NH(CO)X, SO 2 NHX, and NHSO 2 X, wherein X is selected from the group consisting of an alkyl, a substituted alkyl, an aryl, a substituted aryl, an alkylaryl, and a heterocycle. Compounds of group A may be used for treating various diseases or disorders, such as cancer.
    使用阿波戈司宝及其衍生物治疗炎症的方法被披露。此外,还描述了一组具有结构A的化合物,或其药学上可接受的盐、合物、N-氧化物或溶剂化合物: 其中每个R独立地选自H、C(O)X、C(O)NHX、NH(CO)X、SO2NHX和NHSO2X组成的组,其中X选自烷基、取代烷基、芳基、取代芳基、烷基芳基和杂环的组。A组化合物可用于治疗各种疾病或疾病,如癌症。
  • Napthalene-Based Inhibitors of Anti-Apoptotic Proteins
    申请人:Pellecchia Maurizio
    公开号:US20120015992A1
    公开(公告)日:2012-01-19
    Methods of using apogossypol and its derivatives for treating inflammation is disclosed. Also, there is described a group of compounds having structure A, or a pharmaceutically acceptable salt, hydrate, N-oxide, or solvate thereof are provided: wherein each R is independently H, C(O)X, C(O)NHX, NH(CO)X, SO 2 NHX, or NHSO 2 X, wherein X is hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, alkylaryl, substituted alkylaryl, heterocycle, or substituted heterocycle. Compounds of group A may be used for treating various diseases or disorders, such as cancer.
    本文披露了使用阿泊果及其衍生物治疗炎症的方法。此外,还提供了一组具有结构A的化合物,或其药学上可接受的盐、合物、N-氧化物或溶剂化物:其中每个R独立地为H、C(O)X、C(O)NHX、NH(CO)X、SO2NHX或NHSO2X,其中X为氢、烷基、取代烷基、芳基、取代芳基、烷基芳基、取代烷基芳基、杂环或取代杂环。A组化合物可用于治疗各种疾病或疾病,如癌症。
  • US8039668B2
    申请人:——
    公开号:US8039668B2
    公开(公告)日:2011-10-18
  • US8436207B2
    申请人:——
    公开号:US8436207B2
    公开(公告)日:2013-05-07
  • US9115061B2
    申请人:——
    公开号:US9115061B2
    公开(公告)日:2015-08-25
查看更多